Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Kezar Life Sciences, Inc.:
We consent to the use of our report dated March 11, 2021, with respect to the consolidated financial statements of Kezar Life Sciences, Inc., incorporated herein by reference and to the reference to our firm under the heading “Experts” in the prospectus.
| /s/ KPMG LLP |
San Francisco, California
December 17, 2021
